Women Face Heart Risks with Lower Plaque Levels Than Men (American Heart Association Study, Feb 23 2026)

Unveiling Critical Insights from the Latest Research

  • research-publication-news
  • cardiovascular-disease
  • heart-attack-risk
  • women's-health-research
  • women's-heart-health
New0 comments

Be one of the first to share your thoughts!

Add your comments now!

Have your say

Engagement level
a close up of an apple logo on a yellow background
Photo by Philip Oroni on Unsplash

📊 Unveiling the AHA Study's Key Revelations

A groundbreaking study published today in Circulation: Cardiovascular Imaging, an American Heart Association journal, challenges long-held assumptions about heart disease in women. Researchers analyzed data from over 4,200 adults experiencing stable chest pain but with no prior history of coronary artery disease (CAD). These participants, averaging 60 years old and split nearly evenly by gender (51% women), underwent coronary computed tomography angiography (CCTA), a specialized X-ray imaging technique that provides detailed views of the heart's arteries and any plaque buildup within them.

The findings reveal that while women generally have less plaque in their coronary arteries compared to men—present in 55% of women versus 75% of men, with a median plaque volume of 78 cubic millimeters versus 156—their risk of major adverse cardiovascular events (MACE) kicks in earlier and rises more sharply. MACE includes death from any cause, non-fatal heart attack (myocardial infarction), or hospitalization for unstable angina (severe chest pain). Over a median follow-up of 26 months, 2.3% of women and 3.4% of men experienced these events, showing comparable overall risks despite the plaque disparity.

Crucially, women's risk threshold for total plaque burden (the percentage of artery volume occupied by plaque) begins at just 20%, compared to 28% for men. By the time plaque burden reaches levels where hazard ratios hit 1.5 (indicating 50% higher risk), women are at 32% while men are at 42%. Similar patterns hold for non-calcified plaque, a softer, more vulnerable type: risk elevation starts at 7% in women versus 9% in men. This data comes from a subset of the PROMISE trial, a large multicenter study across 193 sites in the U.S. and Canada.Read the full AHA press release for more insights.

Graph comparing plaque burden thresholds for heart risk in women and men from AHA study

Understanding Coronary Plaque: The Silent Buildup

Coronary plaque forms when cholesterol, fat, calcium, and other substances accumulate inside the walls of the coronary arteries, the vessels that supply oxygen-rich blood to the heart muscle. Over time, this buildup narrows the arteries, reducing blood flow—a condition known as atherosclerosis. Plaque can be stable (calcified, harder) or vulnerable (non-calcified or low-attenuation, prone to rupture or erosion).

When plaque ruptures or erodes, it triggers blood clots that can block the artery, causing a heart attack. Traditional views suggested men develop more plaque earlier due to higher rates of risk factors like smoking and higher cholesterol in midlife. However, women often experience plaque erosion rather than rupture, especially pre-menopause, and their smaller coronary arteries mean even modest plaque volumes translate to higher relative burdens.

CCTA quantifies plaque not just by presence but by volume and burden, offering a more precise risk assessment than older methods like coronary artery calcium (CAC) scoring, which mainly detects calcified plaque. For context, the American Heart Association's 2026 Heart Disease and Stroke Statistics report notes cardiovascular disease claims about 433,000 women's lives annually in the U.S., underscoring the urgency of refined diagnostics.

Why Women Aren't 'Protected' by Less Plaque

Senior author Borek Foldyna, M.D., Ph.D., from Harvard Medical School, explains: 'Women are not protected from coronary events despite having lower plaque volumes. Because women have smaller coronary arteries, a small amount of plaque can have a bigger impact.' This relative burden amplifies risk, with moderate plaque hikes disproportionately affecting women.

Post-menopause, estrogen's protective effects wane, accelerating plaque progression. Hormonal shifts, inflammation, microvascular dysfunction (issues in tiny heart vessels), and genetic factors contribute. Unlike men, where risk rises gradually, women's escalates steeply, potentially due to differences in plaque composition—more erosion-prone in females.

Lead author Jan Brendel, M.D., adds that traditional risk models, often male-centric, may miss women's unique atherosclerosis biology. For professionals advancing such research, opportunities abound in clinical research jobs focused on cardiovascular innovations.

  • Smaller artery diameter in women heightens % burden.
  • Hormonal changes post-menopause spike vulnerability.
  • Microvascular issues common, evading standard scans.
  • Inflammation and plaque erosion predominate over rupture.

Recognizing Heart Attack Signs: Women vs. Men

Heart attacks don't always announce themselves dramatically, especially in women. Men typically report crushing chest pain radiating to the arm or jaw, accompanied by sweating and shortness of breath. Women, however, often face subtler symptoms that mimic indigestion or flu:

  • Shortness of breath without chest pain.
  • Nausea, vomiting, or indigestion-like discomfort.
  • Unusual fatigue or weakness, sometimes days prior.
  • Pain in back, neck, jaw, or upper abdomen.
  • Lightheadedness or sudden anxiety.

These atypical presentations lead to delays in seeking care, worsening outcomes. About one-third of women's heart attacks involve non-obstructive disease, where plaque doesn't fully block but still impairs flow via spasm or dysfunction. Awareness saves lives—call emergency services if symptoms persist beyond 5 minutes.

Risk Factors Tailored to Women's Health

Beyond plaque, modifiable risks hit women hard: hypertension (high blood pressure), hypercholesterolemia (high cholesterol), diabetes, obesity, smoking, inactivity, and poor diet. Pregnancy complications like preeclampsia raise lifetime odds by 2-4 times. Autoimmune diseases (e.g., rheumatoid arthritis) and mental health issues like depression also elevate risks.

Per AHA stats, nearly 45% of women over 20 live with some cardiovascular disease. Menopause accelerates risks, with South Asian women facing earlier onset by mid-40s. Genetics play a role too—family history doubles odds.

🎯 Proven Prevention Strategies for Women

Empower yourself with evidence-based steps to slash heart risks by up to 80%:

  • Move daily: Aim for 150 minutes moderate aerobic exercise weekly (brisk walking, swimming) plus strength training twice weekly. Even 30 minutes reduces plaque progression.
  • Eat heart-smart: Embrace Mediterranean-style: fruits, veggies, whole grains, lean proteins, nuts; limit processed foods, sugars, trans fats. Omega-3s from fish combat inflammation.
  • Control metrics: Keep blood pressure <120/80 mmHg, LDL cholesterol <100 mg/dL, fasting glucose normal. Statins if needed post-CCTA.
  • Quit tobacco: Smoking triples risk; cessation halves it within a year.
  • Manage weight/stress: BMI 18.5-24.9 ideal; mindfulness, sleep 7-9 hours nightly.
  • Screen proactively: Discuss CCTA or CAC if family history or symptoms.

Consult providers for personalized plans, especially post-50.Go Red for Women resources offer tools.

Infographic of key prevention steps for women's heart health

Revolutionizing Screening and Diagnosis

This study urges sex-specific thresholds: lower plaque burdens warrant intervention in women. CCTA's quantitative metrics outperform CAC alone, detecting non-calcified plaque. Experts like Julie Marcus, M.D., advocate adjusting treatment starts earlier for at-risk women.

Integrate with ASCVD risk calculators, but adjust for gender. For academics in radiology or cardiology, such advancements highlight faculty positions in medical research.Access the full study abstract.

The Bigger Picture: Transforming Women's Heart Care

Cardiovascular disease kills more women than all cancers combined. Disparities in care—fewer statins, angioplasties for women—persist. This research fuels calls for tailored guidelines, emphasizing non-obstructive disease and microvascular health.

From PROMISE trial insights to AI-enhanced imaging, progress accelerates. Stay ahead via research jobs in higher education driving these changes.

Take Charge: Your Path Forward

Schedule a check-up, track vitals, adopt habits today. Knowledge empowers—share symptoms with loved ones. For career inspiration in health sciences, explore Rate My Professor for top educators, higher ed jobs in medicine, or career advice. University jobs in public health await. Knowledge is prevention; act now for a stronger heart.

Frequently Asked Questions

📊What does the AHA study say about plaque in women vs. men?

The study found women have plaque in 55% of cases vs. 75% in men, with lower volumes (78 mm³ median vs. 156 mm³), but risk starts at lower burdens (20% vs. 28%). Career advice in cardio research.

🔬Why do women face risks with less plaque?

Smaller coronary arteries make plaque more impactful percentage-wise, plus post-menopause changes and erosion-prone plaque.

⚠️What are MACE in this context?

Major adverse cardiovascular events: death, myocardial infarction, or unstable angina hospitalization. Rates similar despite less plaque in women.

🩻How is plaque measured in the study?

Via CCTA quantifying total volume and burden (% vessel volume), including calcified/non-calcified types. Research jobs.

❤️What heart attack symptoms differ in women?

Women often have nausea, fatigue, back pain vs. men's chest pain. Don't ignore subtle signs.

🏃‍♀️How can women prevent heart disease?

Exercise 150 min/week, Mediterranean diet, control BP/cholesterol, quit smoking, manage stress.

📈Should screening thresholds change for women?

Yes, lower plaque burdens signal risk; CCTA better than CAC for nuance.

🌙What role does menopause play?

Risk rises sharply post-menopause due to estrogen loss accelerating plaque.

📉Are there stats on women and CVD deaths?

CVD causes ~433,000 female deaths yearly per AHA 2026 stats, leading killer.

🎓Where to learn more or pursue related careers?

👩‍⚕️Is CCTA recommended for all women?

For those with symptoms or risks; discuss with doctor for personalized screening.